Integrative Approaches for Cancer Survivorship: A Multi-Site Feasibility and Acceptability Study (Aim 2)
This clinical trial is a two-arm pilot randomized controlled trial for non-metastatic breast cancer survivors to determine the feasibility, acceptability, and fidelity of two integrative health approaches and study design in a multi-site setting. Participants (n=104) will be randomized to either the Ayurveda Intervention (AVI) or Facing Forward Health Education Intervention (FFHEI). Integrative health combines biomedical and complementary approaches together in a coordinated way. AVI, a multi-modal intervention, includes nutritional education, lifestyle practices, yoga, and therapeutic touch, called marma, to help the body and mind feel balanced. FFHEI provides health education using self-directed online content and interactive videos based on the latest science in cancer survivorship. This study does not intend to conduct tests of efficacy and is focused on feasibility outcomes.
⁃ Patients
• Age \>= 18
• Able to understand study procedures and to comply with them for the entire length of the study.
• Able to read, write, and understand English.
• Ability of individual or legal guardian/representative to understand a verbal informed consent document, and the willingness to sign it.
• Non-metastatic breast cancer patients who are between 1 and 36 months after completion of primary treatment (i.e., surgery, radiotherapy, chemotherapy) and are in a complete remission.
• Participants should have received chemotherapy as part of their primary treatment.
• Have an impaired quality of life (report a score of 5 or less on question 30 of the European Organisation for Research and Treatment of Cancer Quality of Life Cancer questionnaire (EORTC-QLQ-C30). How would you rate your overall quality of life during the past week?
• Karnofsky Performance Status Score (KPS) \>=60
⁃ Ayurveda Practitioners
⁃ 1\. Must be engaged as an Ayurvedic Intervention practitioner on the Renew study